{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:46:25Z","timestamp":1792737985876,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10067-022-06129-8","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:03:41Z","timestamp":1648515821000},"page":"1965-1978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-9902","authenticated-orcid":false,"given":"Fernanda F\u00e1vero","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus William","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine Raquel","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Klarmann","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane","family":"da Silva Dal Pizzol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"6129_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.rbre.2017.07.002","volume":"57","author":"RE Heymann","year":"2017","unstructured":"Heymann RE, Paiva ES, Martinez JE, Helfenstein M, Rezende MC, Provenza JR et al (2017) New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol Engl Ed 57:467\u2013476. https:\/\/doi.org\/10.1016\/j.rbre.2017.07.002","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"6129_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020020","author":"S Kia","year":"2017","unstructured":"Kia S, Choy E (2017) Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines5020020","journal-title":"Biomedicines"},{"key":"6129_CR3","doi-asserted-by":"publisher","unstructured":"Arnold LM, Clauw DJ (2017) Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgrad Med: 709\u201314. https:\/\/doi.org\/10.1080\/00325481.2017.1336417","DOI":"10.1080\/00325481.2017.1336417"},{"key":"6129_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00482-017-0207-0","volume":"31","author":"C Sommer","year":"2017","unstructured":"Sommer C, Alten R, B\u00e4r KJ, Bernateck M, Br\u00fcckle W, Friedel E et al (2017) Drug therapy of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Springer Verlag 31:274\u2013284. https:\/\/doi.org\/10.1007\/s00482-017-0207-0","journal-title":"Springer Verlag"},{"key":"6129_CR5","doi-asserted-by":"publisher","unstructured":"Higgs JB (2018) Fibromyalgia in primary care. Primary care - clinics in office practice. Elsevier Inc, 325\u201341. https:\/\/doi.org\/10.1016\/j.pop.2018.02.008","DOI":"10.1016\/j.pop.2018.02.008"},{"key":"6129_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, etiopathogenesis and treatment. Nat Rev Rheumatol 16:645\u2013660. https:\/\/doi.org\/10.1038\/s41584-020-00506-w","journal-title":"Nat Rev Rheumatol"},{"key":"6129_CR7","doi-asserted-by":"publisher","unstructured":"Shelton RC (2019) Serotonin and Norepinephrine Reuptake Inhibitors. Handbook of Experimental Pharmacology. Springer New York LLC, p. 145\u201380. https:\/\/doi.org\/10.1007\/164_2018_164","DOI":"10.1007\/164_2018_164"},{"key":"6129_CR8","doi-asserted-by":"publisher","unstructured":"Thorpe J, Shum B, Ra M, Pj W, Gilron I (2018) Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010585.pub2","DOI":"10.1002\/14651858.CD010585.pub2"},{"key":"6129_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.20344\/amp.10433","volume":"31","author":"G Ferreira-Dos-Santos","year":"2018","unstructured":"Ferreira-Dos-Santos G, Sousa DC, Costa J, Vaz-Carneiro A (2018) An\u00e1lise da Revis\u00e3o Cochrane: Pregabalina no Tratamento da Dor Cr\u00f3nica Moderada a Grave em Adultos com Fibromialgia. Cochrane Database Syst Rev. Acta M\u00e9d Port 31:376. https:\/\/doi.org\/10.20344\/amp.10433","journal-title":"Acta M\u00e9d Port"},{"key":"6129_CR10","doi-asserted-by":"publisher","unstructured":"Derry S, Cording M, Pj W, Law S, Phillips T, Ra M (2017) Pregabalin for pain in fibromyalgia in adults (Review). https:\/\/doi.org\/10.1002\/14651858.CD011790.pub2","DOI":"10.1002\/14651858.CD011790.pub2"},{"key":"6129_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292.pub2","author":"P Welsch","year":"2018","unstructured":"Welsch P, \u00dc\u00e7eyler N, Klose P, Walitt B, H\u00e4user W, Patrick W et al (2018) Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010292.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6129_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5935\/abc.20160052","volume":"181","author":"OA Panagiotou","year":"2015","unstructured":"Panagiotou OA (2015) Network meta-analysis: evidence synthesis with mixed treatment comparison Edited by Giuseppe Biondi-Zoccai. Am J Epidemiol 181:288\u2013289. https:\/\/doi.org\/10.5935\/abc.20160052","journal-title":"Am J Epidemiol"},{"key":"6129_CR13","doi-asserted-by":"publisher","unstructured":"Sterne JAC et al (2019) RoB 2: a revised cochrane risk-of-bias tool for randomized trials. BMJ (in press). 1\u201324. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"6129_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39500.677199.AE","author":"HJ Sch\u00fcnemann","year":"2008","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE et al (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (Clinical research ed). https:\/\/doi.org\/10.1136\/bmj.39500.677199.AE","journal-title":"BMJ (Clinical research ed)"},{"key":"6129_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"6129_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-868.00353","volume":"64","author":"DJ Spiegelhalter","year":"2002","unstructured":"Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit. J Royal Statistical Soc B 64:583\u2013639. https:\/\/doi.org\/10.1111\/1467-868.00353","journal-title":"J Royal Statistical Soc B"},{"key":"6129_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/14651858.CD010782.pub2","volume":"2017","author":"\u00dc Nurcan","year":"2013","unstructured":"Nurcan \u00dc, Claudia S, Brian W, Winfried H, \u00dc\u00e7eyler N, Sommer C et al (2013) Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 2017:2\u20135. https:\/\/doi.org\/10.1002\/14651858.CD010782.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6129_CR18","doi-asserted-by":"publisher","unstructured":"Lunn M, Hughes R, Wiffen P (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia (Review). Cochrane Database Syst Rev. Art. No.: CD007115. https:\/\/doi.org\/10.1002\/14651858.CD007115.pub3","DOI":"10.1002\/14651858.CD007115.pub3"},{"key":"6129_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011824","author":"RA Moore","year":"2015","unstructured":"Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2015) Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011824","journal-title":"Cochrane Database Syst Rev"},{"key":"6129_CR20","doi-asserted-by":"publisher","unstructured":"Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA (2016) Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011790.pub2","DOI":"10.1002\/14651858.CD011790.pub2"},{"key":"6129_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2019.1664510","author":"YN Lian","year":"2019","unstructured":"Lian YN, Wang Y, Zhang Y, Yang CX (2019) Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2019.1664510","journal-title":"Int J Neurosci"},{"key":"6129_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01144.x","author":"TG Tzellos","year":"2010","unstructured":"Tzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A et al (2010) Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01144.x","journal-title":"J Clin Pharm Ther"},{"key":"6129_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jpain.2010.09.007","volume":"12","author":"AC Siler","year":"2011","unstructured":"Siler AC, Gardner H, Yanit K, Cushman T, McDonagh M (2011) Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia. J Pain 12:407\u2013415. https:\/\/doi.org\/10.1016\/j.jpain.2010.09.007","journal-title":"J Pain"},{"key":"6129_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/rheumatology\/keq354","volume":"50","author":"W H\u00e4user","year":"2011","unstructured":"H\u00e4user W, Petzke F, \u00dceyler N, Sommer C (2011) Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology 50:532\u2013543. https:\/\/doi.org\/10.1093\/rheumatology\/keq354","journal-title":"Rheumatology"},{"key":"6129_CR25","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3899\/jrheum.100365","volume":"37","author":"LM Arnold","year":"2010","unstructured":"Arnold LM, Clauw D, Wang F, Ahl J, Gaynor PJ, Wohlreich MM (2010) Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 37:2578\u20132586. https:\/\/doi.org\/10.3899\/jrheum.100365","journal-title":"J Rheumatol"},{"key":"6129_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/AJP.0b013e3182510295","volume":"28","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Zhang S, Pangallo BA (2012) Efficacy and safety of duloxetine 30 mg per day: a randomized, double-blind, placebo-controlled study. Clin J Pain 28:775\u2013781. https:\/\/doi.org\/10.1097\/AJP.0b013e3182510295","journal-title":"Clin J Pain"},{"key":"6129_CR27","doi-asserted-by":"publisher","unstructured":"Chappell AS, Bradley LA, Wiltse C, Detke MJ, Souza DND, Spaeth M (2008) Randomized clinical trial of duloxetine for the treatment of fibromyalgia. 91\u2013102. https:\/\/doi.org\/10.2147\/ijgm.s3979","DOI":"10.2147\/ijgm.s3979"},{"key":"6129_CR28","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3899\/jrheum.110569","volume":"38","author":"L Pauer","year":"2011","unstructured":"Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G et al (2011) An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 38:2643\u20132652. https:\/\/doi.org\/10.3899\/jrheum.110569","journal-title":"J Rheumatol"},{"key":"6129_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ et al (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136:432\u2013444. https:\/\/doi.org\/10.1016\/j.pain.2008.02.024","journal-title":"Pain"},{"key":"6129_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/art.1780290510","volume":"29","author":"S Carette","year":"1986","unstructured":"Carette S, McCain GA, Bell DA, Fam AG (1986) Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 29:655\u20139. https:\/\/doi.org\/10.1002\/art.1780290510","journal-title":"Arthritis Rheum"},{"key":"6129_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/art.1780370106","volume":"37","author":"S Carette","year":"1994","unstructured":"Carette S, Bell MJ, Reynolds WJ, Haraoui B, Mccain GA, Bykerk VP et al (1994) Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 37:32\u201340. https:\/\/doi.org\/10.1002\/art.1780370106","journal-title":"Arthritis Rheum"},{"key":"6129_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.1780380906","volume":"38","author":"S Carette","year":"1995","unstructured":"Carette S, Oakson G, Guimont C, Steriade M (1995) Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 38:1211\u20131217. https:\/\/doi.org\/10.1002\/art.1780380906","journal-title":"Arthritis Rheum"},{"key":"6129_CR33","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S et al (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974\u20132984. https:\/\/doi.org\/10.1002\/art.20485","journal-title":"Arthritis Rheum"},{"key":"6129_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D\u2019Souza DN, Goldstein DJ, Iyengar S et al (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119:5\u201315. https:\/\/doi.org\/10.1016\/j.pain.2005.06.031","journal-title":"Pain"},{"key":"6129_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U et al (2008) A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9:792\u2013805. https:\/\/doi.org\/10.1016\/j.jpain.2008.03.013","journal-title":"J Pain"},{"key":"6129_CR36","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE et al (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52:1264\u20131273. https:\/\/doi.org\/10.1002\/art.20983","journal-title":"Arthritis Rheum"},{"key":"6129_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0718-y","volume":"17","author":"M Murakami","year":"2015","unstructured":"Murakami M, Osada K, Mizuno H, Ochiai T, Alev L, Nishioka K (2015) A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Res Ther 17:1\u201313. https:\/\/doi.org\/10.1186\/s13075-015-0718-y","journal-title":"Arthritis Res Ther"},{"key":"6129_CR38","doi-asserted-by":"publisher","unstructured":"Ohta H, Oka H, Usui C, Ohkura M, Suzuki M, Nishioka K. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/ar4056.","DOI":"10.1186\/ar4056"},{"key":"6129_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1300\/J094v04n03_05","volume":"4","author":"F Ginsberg","year":"1996","unstructured":"Ginsberg F, Mancaux A, Joos E, Vanhove P, Famaey J-P (1996) A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Muscoskeletal Pain 4:37\u201347. https:\/\/doi.org\/10.1300\/J094v04n03_05","journal-title":"J Muscoskeletal Pain"},{"issue":"1","key":"6129_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/bja\/aet124","volume":"111","author":"EJ Dansie","year":"2013","unstructured":"Dansie EJ, Turk DC (2013) Assessment of patients with chronic pain. British Journal of Anaesth 111(1):19\u201325","journal-title":"British Journal of Anaesth"},{"key":"6129_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5935\/1806-0013.20160003","volume":"17","author":"SB de Lorena","year":"2016","unstructured":"de Lorena SB, dos PimentelSantos EA, Fernandes VM, Pedrosa MB, Ranzolin A, Duarte ALBP (2016) Evaluation of pain and quality of life of fibromyalgia patients. Genesis Netw 17:8\u201311. https:\/\/doi.org\/10.5935\/1806-0013.20160003","journal-title":"Genesis Netw"},{"key":"6129_CR42","doi-asserted-by":"publisher","unstructured":"Macfarlane GJ, Kronisch C, Atzeni F, H\u00e4user W, Choy EH, Amris K, et al (2017) EULAR recommendations for management of fibromyalgia. Ann Rheum Dis 76. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209724","DOI":"10.1136\/annrheumdis-2016-209724"},{"key":"6129_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-020-00137-5","author":"\u00c1D de Farias","year":"2020","unstructured":"de Farias \u00c1D, Eberle L, Amador TA, da Silva Dal Pizzol T (2020) Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Adv Rheumatol. https:\/\/doi.org\/10.1186\/s42358-020-00137-5","journal-title":"Adv Rheumatol"},{"key":"6129_CR44","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1526-4637.2009.00614.x","volume":"10","author":"AM Hunter","year":"2009","unstructured":"Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE et al (2009) Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med 10:730\u2013738. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00614.x","journal-title":"Pain Med"},{"key":"6129_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/03007995.2018.1450743","volume":"34","author":"LM Arnold","year":"2018","unstructured":"Arnold LM, Choy E, Clauw DJ, Oka H, Whalen E, Semel D et al (2018) An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin 34:1397\u20131409. https:\/\/doi.org\/10.1080\/03007995.2018.1450743","journal-title":"Curr Med Res Opin"},{"key":"6129_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00296-016-3468-5","volume":"36","author":"YH Lee","year":"2016","unstructured":"Lee YH, Song GG (2016) Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Rheumatol Int 36:663\u2013672. https:\/\/doi.org\/10.1007\/s00296-016-3468-5","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06129-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T11:15:00Z","timestamp":1654859700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6129"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06129-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}